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Purpose/Objective: To investigate the impact of surgery, 
oncoplastic surgery versus lumpectomy, on the volume of 
tumor bed delineation in irradiated breast cancer (BC) 
patients. 
Materials and Methods: A consecutive series of 293 BC 
patients were treated with breast conserving surgery 
followed by radiotherapy. Of this series, 44 patients 
underwent an oncoplastic procedure and were included in 
this study. The control group consisted of 67 patients who 
underwent a lumpectomy. The controls were matched for 
location (lateral upper quadrant versus other) and tumor to 
breast ratio (small versus large). For the small tumor to 
breast ratio group we included 2 controls for each 
oncoplastic patient. For the group with large tumor to breast 
ratios we included all available patients (1 to 1). The tumor 
bed was delineated based on the presence of the surgical 
clips, hematoma, seroma and/or other surgery-induced 
changes and interpretation of radiology, pathology and 
surgical reports. The association between surgery 
(oncoplastic surgery versus lumpectomy) and delineated 
tumor bed volumes in cm3 was assessed with linear regression 
analyses. Here we present the crude association (using 
univariable analysis) and the association corrected for 
confounding factors (using multivariable analysis). Only 
confounders that changed the association more than 10% 
were included. In these analyses the outcome delineated 
tumor bed volume was log-transformed, the estimated beta’s 
represent the change in log tumor bed volume.  
Results: The oncoplastic operated patients had a radiological 
larger median tumor diameter (21 mm versus 14 mm) than 
the lumpectomy patients. The volume of the pathological 
specimen was not significantly different between the two 
groups: 148.8 cm3 in the oncoplastic group and 135.0 cm3 in 
the lumpectomy group. The median delineated tumor bed 
volume was significantly larger after oncoplastic surgery 
compared to lumpectomy alone (26.3 cm3 vs. 16.4 cm3, 
p<0.001). In the univariable analysis the delineated tumor 
bed volume was 1.7 (β = 0.547, 95% CI 0.297-0.797) times 
larger in patients with an oncoplastic procedure than in the 
patients who underwent a lumpectomy only. After correcting 
for confounders (presence of postoperative seroma and 
radiological tumor diameter (mm)) the delineated tumor bed 
volume after the oncoplastic procedure was 1.9 (β = 0.616, 
95% CI 0.353-0.879) times larger than after a lumpectomy 
only. 
Conclusions: Oncoplastic surgery in breast conserving 
treatment for breast cancer results in larger tumor bed 
volumes for radiotherapy. 
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Purpose/Objective: Neoadjuvant radiochemotherapy (NRT-
CHX) is an innovative technique for the treatment of patients 
with locally advanced non inflammatory breast cancer 
(LABC). The aim of this study was to analyze the long term 
cosmetic outcome in breast conserving and mastectomy 
patients after NRT-CHX. 
Materials and Methods: In a time period from 1991 to 1998 a 
total of 315 LABC patients (cT1-cT4/cN0-N1) were treated 
with NRT-CHX. 160 patients received breast conserving 
surgery (BCS) and 154 patients mastectomy. One patient had 
no surgery. Preoperative radiotherapy (RT) consisted of 
external beam radiation therapy (EBRT) of 50 Gy (5 × 2 
Gy/week) to the breast and the supra-/infraclavicular lymph 
nodes (n=255) combined with a consecutive electron boost in 
214 cases or - a 10-Gy interstitial boost with (192)Ir 
afterloading before EBRT in n=101 cases. Chemotherapy with 
CMF and AC/EC was administered prior to RT in 192 patients, 
and Mitoxantrone concomitantly in n=113 patients; 10 
patients received no chemotherapy. The cosmetic outcome 
was assessed by patient questionnaire in 2013. A panel with 5 
independent investigators evaluated the cosmetic outcome in 
4 grades (excellent, good, moderate and bad). The breast 
retraction assessment (BRA) was quantified by van Limbergen 
Score. Quality-of-life was measured by EORTC QLQ-C30 and 
BR23 and late radiation side effects by LENT/SOMA scale. 
Results: In 64 patients after breast conserving surgery and 43 
patients after mastectomy a long term follow up of the 
cosmetic outcome was possible. Most patients rated their 
overall cosmetics as 'excellent' or 'good' (94% in the breast 
conserving group and 55.8% of the mastectomy group). The 
results for the mastectomy group is in detail: excellent: 
27.91%, good: 27.91%, moderate: 39.53% and bad 4.65%. 
After a follow up of 16-22 years we did not detect any grade 
III or IV late side effects in both groups. The median BRA 
score after breast conserving surgery was 2.9 and the over-all 
quality of life (QLQ-C30) was rated 'excellent' or good in 82%. 
Conclusions: NRT-CHX is associated with an acceptable 
radiotherapeutic toxicity and a good cosmetic outcome. 
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Purpose/Objective: Left sided breast cancer poses a 
significant challenge in sparing the heart and specifically the 
left descending coronary vessels (LCV). Often, a compromise 
between PTV coverage and OAR sparing must be made. Lung 
Gating is seen as a useful method to maximize both. 
However, it is always associated with increased complexity, 
cost and time. We prospectively evaluated the cost-benefit 
of a modern system implemented in a busy community 
hospital environment.  
Materials and Methods: A lung gating system based on the 
breath-hold technique (SDX, QFix, Avondale PN, USA)  
